HK1129205A1 - Adjuvant-sparing multi-dose influenza vaccination regimen - Google Patents

Adjuvant-sparing multi-dose influenza vaccination regimen

Info

Publication number
HK1129205A1
HK1129205A1 HK09108245.7A HK09108245A HK1129205A1 HK 1129205 A1 HK1129205 A1 HK 1129205A1 HK 09108245 A HK09108245 A HK 09108245A HK 1129205 A1 HK1129205 A1 HK 1129205A1
Authority
HK
Hong Kong
Prior art keywords
sparing
adjuvant
vaccination regimen
influenza vaccination
dose influenza
Prior art date
Application number
HK09108245.7A
Other languages
English (en)
Inventor
Giudice Giuseppe Del
Riccardo Manetti
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38832174&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1129205(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1129205A1 publication Critical patent/HK1129205A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
HK09108245.7A 2006-06-15 2009-09-08 Adjuvant-sparing multi-dose influenza vaccination regimen HK1129205A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81466506P 2006-06-15 2006-06-15
PCT/IB2007/002724 WO2007144772A2 (en) 2006-06-15 2007-06-15 Adjuvant-sparing multi-dose influenza vaccination regimen

Publications (1)

Publication Number Publication Date
HK1129205A1 true HK1129205A1 (en) 2009-11-20

Family

ID=38832174

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09108245.7A HK1129205A1 (en) 2006-06-15 2009-09-08 Adjuvant-sparing multi-dose influenza vaccination regimen

Country Status (18)

Country Link
US (3) US20090220545A1 (xx)
EP (1) EP2032163B1 (xx)
JP (2) JP5566687B2 (xx)
KR (1) KR20090016704A (xx)
CN (1) CN101500603A (xx)
AU (1) AU2007258874B2 (xx)
BR (1) BRPI0713150A8 (xx)
CA (1) CA2657989A1 (xx)
CY (1) CY1114315T1 (xx)
DK (1) DK2032163T3 (xx)
EA (1) EA017441B1 (xx)
ES (1) ES2401484T3 (xx)
HK (1) HK1129205A1 (xx)
PL (1) PL2032163T3 (xx)
PT (1) PT2032163E (xx)
SI (1) SI2032163T1 (xx)
WO (1) WO2007144772A2 (xx)
ZA (1) ZA200810582B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11707520B2 (en) 2005-11-03 2023-07-25 Seqirus UK Limited Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
PT2368572T (pt) * 2005-11-04 2020-06-16 Seqirus Uk Ltd Vacinas com adjuvante dotadas de antigénios não-virião preparados a partir de vírus da gripe cultivado em cultura celular
EP2889042A3 (en) * 2008-03-18 2015-10-14 Novartis AG Improvements in preparation of influenza virus vaccine antigens
GB0905570D0 (en) * 2009-03-31 2009-05-13 Novartis Ag Combined vaccines
KR101825697B1 (ko) 2009-02-10 2018-02-05 노파르티스 아게 감소된 양의 스쿠알렌을 포함하는 인플루엔자 백신
KR101176305B1 (ko) * 2009-10-14 2012-08-23 웅진코웨이주식회사 붉나무 추출물을 포함하는 인플루엔자 바이러스 감염의 예방용 조성물, 상기 조성물을 포함하는 기상필터 및 상기 필터를 포함하는 공기청정기
US20110126501A1 (en) 2009-10-16 2011-06-02 Woongjin Coway Co., Ltd. Composition for prevention of influenza viral infection comprising tannic acid, air filter comprising the same and air cleaning device comprising the filter
KR101153630B1 (ko) * 2009-10-16 2012-06-18 웅진코웨이주식회사 타닌산을 포함하는 인플루엔자 바이러스 감염의 예방용 조성물, 상기 조성물을 포함하는 기상필터 및 상기 필터를 포함하는 공기청정기
JP5988435B2 (ja) * 2010-01-24 2016-09-07 ノバルティス アーゲー 放射線照射された生分解性微粒子
US8852157B2 (en) 2010-02-21 2014-10-07 Innovative Bottles, Llc Disposable items made from bioplastic resins
CN102232042B (zh) * 2010-02-21 2015-01-14 创新瓶业有限责任公司 生物可降解药房容器以及安全盖
WO2011141443A1 (en) * 2010-05-11 2011-11-17 Intervet International B.V. Vaccine against mycoplasma hyopneumoniae, suitable for administration in the presence of maternally derived antibodies
RU2013144207A (ru) * 2011-03-02 2015-04-10 Новартис Аг Комбинированные вакцины с пониженными дозами антигена и/или адъюванта
WO2016011343A1 (en) 2014-07-17 2016-01-21 The Trustees Of The University Of Pennsylvania Her3 peptides and dendritic cell vaccines
WO2017014810A1 (en) * 2015-07-17 2017-01-26 Czerniecki Brian J Identification of immunogenic mhc class ii peptides for immune-based therapy
EP3213786A4 (en) * 2014-10-30 2018-07-11 Chugai Seiyaku Kabushiki Kaisha Pre-filled syringe preparation with needle, which is equipped with syringe cap
AR103244A1 (es) 2015-02-03 2017-04-26 Merz Pharma Gmbh & Co Kgaa Recipiente precargado con toxina botulínica
BR112017028011A2 (pt) 2015-06-26 2018-08-28 Seqirus Uk Ltd vacinas de gripe correspondentes antigenicamente
JP2021533157A (ja) * 2018-08-07 2021-12-02 ウィスコンシン アルムニ リサーチ ファンデイション 組換えの生物学的に封じ込められたフィロウイルスワクチン
US11851648B2 (en) 2019-02-08 2023-12-26 Wisconsin Alumni Research Foundation (Warf) Humanized cell line
EP4022046A2 (en) 2019-08-27 2022-07-06 Wisconsin Alumni Research Foundation (WARF) Recombinant influenza viruses with stabilized ha for replication in eggs

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU627226B2 (en) * 1988-08-25 1992-08-20 Liposome Company, Inc., The Influenza vaccine and novel adjuvants
WO1990001947A1 (en) 1988-08-25 1990-03-08 The Liposome Company, Inc. Affinity associated vaccine
GB9923176D0 (en) * 1999-09-30 1999-12-01 Smithkline Beecham Biolog Novel composition
DE10012370A1 (de) 2000-03-14 2001-09-27 Chiron Behring Gmbh & Co Adjuvans für Vakzinen
DE602004028468D1 (de) * 2003-06-17 2010-09-16 Mannkind Corp Haltung von immunantworten gegen mhc-klasse-i-beschränkte epitope, für prophylaktische oder therapeutische zwecke
US20080254065A1 (en) * 2004-03-09 2008-10-16 Chiron Corporation Influenza Virus Vaccines
EP2397153A1 (en) 2005-03-23 2011-12-21 GlaxoSmithKline Biologicals S.A. Novel composition
WO2007052057A2 (en) * 2005-11-04 2007-05-10 Novartis Vaccines And Diagnostics Srl Adminstration routes for priming/boosting with influenza vaccines
TWI457133B (zh) * 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
EP2043682B1 (en) 2006-07-17 2014-04-02 GlaxoSmithKline Biologicals S.A. Influenza vaccine

Also Published As

Publication number Publication date
ES2401484T3 (es) 2013-04-22
EP2032163B1 (en) 2013-01-23
US8808686B2 (en) 2014-08-19
JP2014098038A (ja) 2014-05-29
US20120039934A1 (en) 2012-02-16
KR20090016704A (ko) 2009-02-17
DK2032163T3 (da) 2013-03-25
EA200970013A1 (ru) 2009-06-30
EP2032163A2 (en) 2009-03-11
US20090220545A1 (en) 2009-09-03
PL2032163T3 (pl) 2013-06-28
AU2007258874A1 (en) 2007-12-21
WO2007144772A3 (en) 2008-03-27
JP5566687B2 (ja) 2014-08-06
CN101500603A (zh) 2009-08-05
EA017441B1 (ru) 2012-12-28
PT2032163E (pt) 2013-04-11
ZA200810582B (en) 2009-09-30
JP5981951B2 (ja) 2016-08-31
US9901630B2 (en) 2018-02-27
BRPI0713150A8 (pt) 2017-08-22
AU2007258874B2 (en) 2013-11-14
US20140370053A1 (en) 2014-12-18
JP2009539965A (ja) 2009-11-19
WO2007144772A2 (en) 2007-12-21
BRPI0713150A2 (pt) 2012-03-27
CY1114315T1 (el) 2016-08-31
SI2032163T1 (sl) 2013-05-31
CA2657989A1 (en) 2007-12-21

Similar Documents

Publication Publication Date Title
HK1129205A1 (en) Adjuvant-sparing multi-dose influenza vaccination regimen
IL196024A0 (en) Influenza vaccine
HK1143085A1 (en) Low-additive influenza vaccines
PT2422810E (pt) Vacina da gripe
GB0607088D0 (en) Vaccine
GB0810305D0 (en) Influenza vaccination
EP1998814A4 (en) NEW VACCINES AGAINST INFLUENZA M2
ZA200809056B (en) Influenza virus vaccine
HK1129836A1 (zh) 疫苗
EP2318044A4 (en) INFLUENZA VACCINES
ZA200901592B (en) Vaccine
EP2240199A4 (en) INFLUENZA VACCINES
ZA200900062B (en) Influenza vaccine
GB0625593D0 (en) Vaccine
GB0625453D0 (en) Influenza vaccine
GB0619090D0 (en) Influenza vaccine
GB0623218D0 (en) Influenza vaccine
GB0623865D0 (en) Influenza vaccine
GB0618195D0 (en) Influenza vaccine
GB0723987D0 (en) Influenza vaccine reagents
GB0620815D0 (en) Vaccine
GB0619826D0 (en) Vaccine
GB0620337D0 (en) Vaccine
GB0608962D0 (en) Vaccine
GB0607087D0 (en) Vaccine

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20230615